United States Radioactive Monoclonal Antibody Market Research Report Forecast 2017-2021

March 2017 | 111 pages | ID: U74B1576C59EN
S&P Consulting

Abstracts

The United States Radioactive Monoclonal Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Radioactive Monoclonal Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Radioactive Monoclonal Antibody market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

United States Radioactive Monoclonal Antibody Market: Product Segment Analysis

Type 1
Type 2
Type 3

United States Radioactive Monoclonal Antibody Market: Application Segment Analysis

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 RADIOACTIVE MONOCLONAL ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Radioactive Monoclonal Antibody
1.2 Radioactive Monoclonal Antibody Market Segmentation by Type
  1.2.1 United States Production Market Share of Radioactive Monoclonal Antibody by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Radioactive Monoclonal Antibody Market Segmentation by Application
  1.3.1 Radioactive Monoclonal Antibody Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Radioactive Monoclonal Antibody (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON RADIOACTIVE MONOCLONAL ANTIBODY INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES RADIOACTIVE MONOCLONAL ANTIBODY MARKET COMPETITION BY MANUFACTURERS

3.1 United States Radioactive Monoclonal Antibody Production and Share by Manufacturers (2015 and 2016)
3.2 United States Radioactive Monoclonal Antibody Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Radioactive Monoclonal Antibody Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Radioactive Monoclonal Antibody Manufacturing Base Distribution, Production Area and Product Type
3.5 Radioactive Monoclonal Antibody Market Competitive Situation and Trends
  3.5.1 Radioactive Monoclonal Antibody Market Concentration Rate
  3.5.2 Radioactive Monoclonal Antibody Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES RADIOACTIVE MONOCLONAL ANTIBODY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Radioactive Monoclonal Antibody Production and Market Share by Type (2012-2017)
4.2 United States Radioactive Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
4.3 United States Radioactive Monoclonal Antibody Price by Type (2012-2017)
4.4 United States Radioactive Monoclonal Antibody Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES RADIOACTIVE MONOCLONAL ANTIBODY MARKET ANALYSIS BY APPLICATION

5.1 United States Radioactive Monoclonal Antibody Consumption and Market Share by Application (2012-2017)
5.2 United States Radioactive Monoclonal Antibody Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES RADIOACTIVE MONOCLONAL ANTIBODY MANUFACTURERS ANALYSIS

6.1 Pfizer Inc. (USA)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Abbott Laboratories (USA)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Genentech Inc. (USA)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 GlaxoSmithKline Plc (UK)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Immunomedics, Inc. (USA)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Indevus Pharmaceuticals Inc. (USA)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Novartis AG (Switzerland)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 OSI Pharmaceuticals, Inc. (USA)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Paladin Labs Inc. (Canada)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 RADIOACTIVE MONOCLONAL ANTIBODY MANUFACTURING COST ANALYSIS

7.1 Radioactive Monoclonal Antibody Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Radioactive Monoclonal Antibody

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Radioactive Monoclonal Antibody Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES RADIOACTIVE MONOCLONAL ANTIBODY MARKET FORECAST (2017-2021)

11.1 United States Radioactive Monoclonal Antibody Production, Revenue Forecast (2017-2021)
11.2 United States Radioactive Monoclonal Antibody Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Radioactive Monoclonal Antibody Production Forecast by Type (2017-2021)
11.4 United States Radioactive Monoclonal Antibody Consumption Forecast by Application (2017-2021)
11.5 Radioactive Monoclonal Antibody Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Radioactive Monoclonal Antibody
Table Classification of Radioactive Monoclonal Antibody
Figure United States Sales Market Share of Radioactive Monoclonal Antibody by Type in 2015
Table Application of Radioactive Monoclonal Antibody
Figure United States Sales Market Share of Radioactive Monoclonal Antibody by Application in 2015
Figure United States Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2021)
Figure United States Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2021)
Table United States Radioactive Monoclonal Antibody Sales of Key Manufacturers (2015 and 2016)
Table United States Radioactive Monoclonal Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Radioactive Monoclonal Antibody Sales Share by Manufacturers
Figure 2016 Radioactive Monoclonal Antibody Sales Share by Manufacturers
Table United States Radioactive Monoclonal Antibody Revenue by Manufacturers (2015 and 2016)
Table United States Radioactive Monoclonal Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Radioactive Monoclonal Antibody Revenue Share by Manufacturers
Table 2016 United States Radioactive Monoclonal Antibody Revenue Share by Manufacturers
Table United States Market Radioactive Monoclonal Antibody Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Radioactive Monoclonal Antibody Average Price of Key Manufacturers in 2015
Figure Radioactive Monoclonal Antibody Market Share of Top 3 Manufacturers
Figure Radioactive Monoclonal Antibody Market Share of Top 5 Manufacturers
Table United States Radioactive Monoclonal Antibody Sales by Type (2012-2017)
Table United States Radioactive Monoclonal Antibody Sales Share by Type (2012-2017)
Figure United States Radioactive Monoclonal Antibody Sales Market Share by Type in 2015
Table United States Radioactive Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
Table United States Radioactive Monoclonal Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Radioactive Monoclonal Antibody by Type (2012-2017)
Table United States Radioactive Monoclonal Antibody Price by Type (2012-2017)
Figure United States Radioactive Monoclonal Antibody Sales Growth Rate by Type (2012-2017)
Table United States Radioactive Monoclonal Antibody Sales by Application (2012-2017)
Table United States Radioactive Monoclonal Antibody Sales Market Share by Application (2012-2017)
Figure United States Radioactive Monoclonal Antibody Sales Market Share by Application in 2015
Table United States Radioactive Monoclonal Antibody Sales Growth Rate by Application (2012-2017)
Figure United States Radioactive Monoclonal Antibody Sales Growth Rate by Application (2012-2017)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genentech Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radioactive Monoclonal Antibody
Figure Manufacturing Process Analysis of Radioactive Monoclonal Antibody
Figure Radioactive Monoclonal Antibody Industrial Chain Analysis
Table Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015
Table Major Buyers of Radioactive Monoclonal Antibody
Table Distributors/Traders List
Figure United States Radioactive Monoclonal Antibody Production and Growth Rate Forecast (2017-2021)
Figure United States Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Table United States Radioactive Monoclonal Antibody Production Forecast by Type (2017-2021)
Table United States Radioactive Monoclonal Antibody Consumption Forecast by Application (2017-2021)